Curaleaf Holdings (Curaleaf Holdings) FCF Margin % : 7.58% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Curaleaf Holdings FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Curaleaf Holdings's Free Cash Flow for the three months ended in Mar. 2024 was $26 Mil. Curaleaf Holdings's Revenue for the three months ended in Mar. 2024 was $339 Mil. Therefore, Curaleaf Holdings's FCF Margin % for the quarter that ended in Mar. 2024 was 7.58%.

As of today, Curaleaf Holdings's current FCF Yield % is 1.10%.

The historical rank and industry rank for Curaleaf Holdings's FCF Margin % or its related term are showing as below:

CURLF' s FCF Margin % Range Over the Past 10 Years
Min: -101.23 Med: -19.25 Max: 3.4
Current: 3.4

During the past 10 years, the highest FCF Margin % of Curaleaf Holdings was 3.40%. The lowest was -101.23%. And the median was -19.25%.

CURLF's FCF Margin % is ranked better than
59.69% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.03 vs CURLF: 3.40

Curaleaf Holdings FCF Margin % Historical Data

The historical data trend for Curaleaf Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curaleaf Holdings FCF Margin % Chart

Curaleaf Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-54.47

-18.18

-19.25

-6.92

0.37

Curaleaf Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-4.64	2.41	8.90	-5.05	7.58

Competitive Comparison of Curaleaf Holdings's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Curaleaf Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curaleaf Holdings's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curaleaf Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Curaleaf Holdings's FCF Margin % falls into.

Curaleaf Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Curaleaf Holdings's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	4.958	/	1346.632
	=	0.37 %

Curaleaf Holdings's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	25.675	/	338.932
	=	7.58 %

Curaleaf Holdings FCF Margin % Related Terms

Thank you for viewing the detailed overview of Curaleaf Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Curaleaf Holdings (Curaleaf Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curaleaf Holdings Inc (OTCPK:CURLF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

CURA:Canada

Address

420 Lexington Avenue, Suite 2035, New York, NY, USA, 10170-0052

Website

https://www.curaleaf.com

Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 18 states. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.